Weekly Digest – June 2026 Weekly Digest – June 2026 23 June 2026: European Commission approves Trodelvy for first-line metastatic TNBC Gilead Sciences has received European Commission approval for Trodelvy as a first-line treatment for adult patients with unresectable locally […]